mesothelioma law firm

Thu, 23 Apr 2015 19:16:13 GMT

Mesothelioma Immunotherapy Vaccine Receives Orphan Drug Designation from ...
PharmiWeb.com (press release)
The mesothelioma law firm of Baron & Budd reports the U.S. Food and Drug Administration has granted orphan drug administration to CRS-207 an immunotherapy vaccine that could greatly impact treatment for malignant pleural mesothelioma.

and more »
Thu, 23 Apr 2015 17:18:58 GMT

Mesothelioma Immunotherapy Vaccine Receives Orphan Drug Designation from ...
Digital Journal
DALLAS--(Business Wire)--The mesothelioma law firm of Baron & Budd reports the U.S. Food and Drug Administration has granted orphan drug administration to CRS-207, an immunotherapy vaccine that could greatly impact treatment for malignant pleural ...

and more »
Thu, 23 Apr 2015 17:13:24 GMT

Mesothelioma Immunotherapy Vaccine Receives Orphan Drug Designation from ...
MarketWatch
DALLAS, Apr 23, 2015 (BUSINESS WIRE) -- The mesothelioma law firm of Baron & Budd reports the U.S. Food and Drug Administration has granted orphan drug administration to CRS-207, an immunotherapy vaccine that could greatly impact treatment for ...

and more »